| Dec'19 | Dec'18 | Dec'17 | Dec'16 | |||
|---|---|---|---|---|---|---|
Collaboration revenue | ||||||
4,365 | 1,187 | - | - | |||
Operating expenses: | ||||||
Research and development | ||||||
82,896 | 54,965 | 35,691 | 13,916 | |||
General and administrative | ||||||
19,409 | 11,806 | 6,072 | 5,064 | |||
Total operating expenses | ||||||
102,305 | 66,771 | 41,763 | 18,980 | |||
Loss from operations | ||||||
-97,940 | -65,584 | -41,763 | -18,980 | |||
Interest income, net | ||||||
3,507 | 809 | 386 | 230 | |||
Net loss | ||||||
-94,433 | -64,775 | -41,377 | -18,750 | |||
Other comprehensive (loss) gain: | ||||||
Unrealized (loss) gain on marketable securities, net of tax | ||||||
109 | -11 | -71 | -3 | |||
Net and comprehensive loss | ||||||
-94,324 | -64,786 | -41,448 | -18,753 | |||
Net loss per share, basic and diluted | ||||||
-2.81 | -7.26 | -20.70 | -11.21 | |||
Weighted-average number of shares used in computing net loss per share, basic and diluted | ||||||
33,554 | 8,919 | 1,999 | 1,672 | |||